Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (23)

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

  3. Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: Data of the Spanish ABPM registry

    Journal of Hypertension, Vol. 32, Núm. 5, pp. 1016-1024

2013

  1. Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance

    Journal of Hypertension, Vol. 31, Núm. 1, pp. 103-108

  2. Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients

    Blood Pressure, Vol. 22, Núm. 1, pp. 39-44

2011

  1. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes

    Hypertension Research, Vol. 34, Núm. 11, pp. 1185-1189

  2. Validation of a therapeutic scheme for the treatment of resistant hypertension

    Journal of the American Society of Hypertension, Vol. 5, Núm. 6, pp. 498-504

2009

  1. Application of hypertension guidelines in clinical practice: Implementation of the 2007 ESH/ESC European practice Guidelines in Spain

    Journal of Hypertension, Vol. 27, Núm. SUPPL. 3

  2. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients

    Hypertension, Vol. 53, Núm. 3, pp. 466-472

  3. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

    Journal of Hypertension, Vol. 27, Núm. 11, pp. 2121-2158

  4. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

  5. Response to nondipping in patients with hypertension

    Hypertension

  6. Target organ damage: How to detect it and how to treat it?

    Journal of Hypertension, Vol. 27, Núm. SUPPL. 3

  7. The ADVANCE trial: Clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus

    American Journal of Cardiovascular Drugs, Vol. 9, Núm. 5, pp. 283-291

2008

  1. Clinical characteristics of isolated clinic hypertension

    Journal of Hypertension, Vol. 26, Núm. 3, pp. 438-445

2007

  1. Management of cardiovascular risk factors in patients with metabolic syndrome

    Cardiovascular and Hematological Agents in Medicinal Chemistry, Vol. 5, Núm. 3, pp. 209-214

  2. Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: The Spanish Ambulatory Blood Pressure Monitoring Registry

    Journal of Hypertension, Vol. 25, Núm. 12, pp. 2406-2412

2003

  1. Efecto del tratamiento antihipertensivo con irbesartán sobre el riesgo cardiovascular absoluto

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 183-188

2002

  1. ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: The end of the search or a need for further investigations?

    American Journal of Hypertension

  2. Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity

    Medicina Clinica